Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 



Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network

The purpose of this administrative supplement is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON).

Application Deadline: December 15, 2018



Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program

Through this FOA, the NCI intends to: support seven region-based “hubs” or networks to facilitate underrepresented investigator/trainee recruitment and career/professional development; provide enhanced capacity in the area of cancer health disparities research; and promote CHD research-related infrastructure development and evaluation.

Application Deadline: December 17, 2018



Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U54 and U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to establish centers of collaborating investigators with the goal of identifying and  advancing research opportunities for translating immunotherapy concepts  for children and adolescents with cancer toward clinical applications.

Application Deadline: December 17, 2018


Alex's Lemonade Stand Foundation Grants

The innovative grant program funds crucial research that can make a real and important difference for children with cancer.

• Epidemiology Grant: To support the research of investigators who have a specific focus on the epidemiology of childhood cancer, early detection of childhood cancer, or the prevention of childhood cancer. Application Deadline: December 17, 2018 Earliest 
• Young Investigator Grant: To fill the need for startup funds for less experienced researchers to pursue promising research ideas, as well as encourage and cultivate the best and brightest researchers of the future and lead to long-term research projects. Application Deadline: December 17, 2018

https://www.alexslemonade.org/researchers-reviewers/applicants


Elsa U. Pardee Foundation Research Grants

These grants fund research directed toward identifying new treatments or cures for cancer and are designed to allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.

Application Deadline: December 31, 2018



Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42) (R43/R44)

The goal of this FOA is to solicit applications from small business concerns (SBCs) to initiate early research ultimately leading to the commercialization of understudied proteins identified in the "Illuminating the Druggable Genome" project.

Application Deadline: January 5, 2019



NCCN Taiho Trifluridine/Tipiracil Research Grant

NCCN is pleased to announce that it is collaborating with Taiho Oncology, Inc. to offer a new opportunity for the design and performance of clinical and correlative studies of trifluridine/tipiracil, in the treatment of gastrointestinal (GI) malignancies and other solid tumors.

Application Deadline: January 7, 2019



Mark Foundation for Cancer Research ASPIRE Award

ASPIRE Awards are designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities.

Application Deadline: January 7, 2019



Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) 

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to increase case ascertainment and appropriate follow-up care, optimizing the  delivery of evidence-based healthcare for individuals at high risk of  cancer due to an inherited genetic susceptibility. 

Application Deadline: January 9, 2019 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-017.html 

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


Communication and Decision Making for Individuals with Inherited Cancer Syndromes

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer.

Application Deadline: January 9, 2018


Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


NCI Research Specialist Award (R50)

This award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.

Application Deadline: January 11, 2019

https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/r50


NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

This FOA invites grant applications for the Research  Specialist Award (R50) in any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Through this FOA, the NCI invites grant applications for the Research Specialist Award (R50) in  any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this specific FOA is to expand Cancer Immunoprevention Research Projects as components of IOTN, which also includes Cancer Immunotherapy Research Projects.

Application Deadline: February 8, 2019


Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to expand organ site-specific Cancer Immunotherapy Research Projects as components of IOTN.

Application Deadline: February 8, 2019


Accelerating Colorectal Cancer Screening and follow-up through Implementation Science

The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care in regions of the United States where screening rates are below national standards.

Application Deadline: February 11, 2019


Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA intends to create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. 

Application Deadline: February 11, 2019 


Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to develop Immuno-engineering to Improve Immunotherapy (i3) Centers, as new components of the Immuno-Oncology Translation Network (IOTN).

Application Deadline: February 11, 2019


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research

This FOA encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Application Deadline: February 11, 2019



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Application Deadline: February 22, 2019


Yale Scholars in Implementation Science (YSIS) Career Development Program

The YSIS Career Development Program is an NIH-funded K12 program within the Yale Center for Implementation Science at the Yale School of Medicine. Funded by the NIH’s National Heart, Lung, and Blood Institute, it is designed to train junior faculty and postdoctoral fellows late-stage dissemination and implementation science.

Application Deadline: March 1, 2019



Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing research for commercial development of novel cancer-relevant technologies.

Application Deadline: April 5, 2019

View the SBIR grant application>>


Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries, and low-resource settings in the US.

Application Deadline: April 5, 2019

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants.  



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of this Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Internal Deadline: December 13, 2018


Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to Luminary@ynhh.org